JP2005519885A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519885A5 JP2005519885A5 JP2003554642A JP2003554642A JP2005519885A5 JP 2005519885 A5 JP2005519885 A5 JP 2005519885A5 JP 2003554642 A JP2003554642 A JP 2003554642A JP 2003554642 A JP2003554642 A JP 2003554642A JP 2005519885 A5 JP2005519885 A5 JP 2005519885A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- halogen
- heteroatom
- hydrogen
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 **N(CCC1N(*)S(*)(=O)=O)C1=O Chemical compound **N(CCC1N(*)S(*)(=O)=O)C1=O 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0130705.7A GB0130705D0 (en) | 2001-12-21 | 2001-12-21 | Chemical compounds |
| PCT/EP2002/014826 WO2003053925A1 (en) | 2001-12-21 | 2002-12-20 | Pyrrolidine-2-ones as factor xa inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005519885A JP2005519885A (ja) | 2005-07-07 |
| JP2005519885A5 true JP2005519885A5 (https=) | 2006-01-26 |
Family
ID=9928210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003554642A Pending JP2005519885A (ja) | 2001-12-21 | 2002-12-20 | 第ｘａ因子阻害剤としてのピロリジン−２−オン |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20050059726A1 (https=) |
| EP (1) | EP1456172A1 (https=) |
| JP (1) | JP2005519885A (https=) |
| KR (1) | KR20040072666A (https=) |
| CN (1) | CN100364971C (https=) |
| AR (1) | AR037928A1 (https=) |
| AU (1) | AU2002366747A1 (https=) |
| BR (1) | BR0215200A (https=) |
| CA (1) | CA2471461A1 (https=) |
| CO (1) | CO5590896A2 (https=) |
| GB (1) | GB0130705D0 (https=) |
| HU (1) | HUP0500137A2 (https=) |
| IL (1) | IL162454A0 (https=) |
| IS (1) | IS7316A (https=) |
| MX (1) | MXPA04006139A (https=) |
| MY (1) | MY141579A (https=) |
| NO (1) | NO20042990L (https=) |
| NZ (1) | NZ533129A (https=) |
| PL (1) | PL371008A1 (https=) |
| RU (1) | RU2318807C2 (https=) |
| TW (1) | TWI262075B (https=) |
| WO (1) | WO2003053925A1 (https=) |
| ZA (1) | ZA200404147B (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200307667A (en) | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| GB0314299D0 (en) * | 2003-06-19 | 2003-07-23 | Glaxo Group Ltd | Chemical compounds |
| GB0314373D0 (en) * | 2003-06-19 | 2003-07-23 | Glaxo Group Ltd | Chemical compounds |
| EP1641752A1 (en) | 2003-06-19 | 2006-04-05 | Glaxo Group Limited | 3- sulfonylamino- pyrrolidine- 2- one derivatives as inhibitors of factor xa |
| GB0314370D0 (en) * | 2003-06-19 | 2003-07-23 | Glaxo Group Ltd | Chemical compounds |
| US7169795B2 (en) | 2003-09-30 | 2007-01-30 | Bristol Myers Squibb Company | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| US7381728B2 (en) | 2004-07-28 | 2008-06-03 | Glaxo Group Limited | Piperazine derivatives useful for the treatment of gastrointestinal disorders |
| DE102004062544A1 (de) | 2004-12-24 | 2006-07-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Pyrrolidinone, deren Herstellung und deren Verewendung als Arzneimittel |
| DE102005008649A1 (de) | 2005-02-25 | 2006-09-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Pyrrolidinone, deren Herstellung und deren Verwendung als Arzneimittel |
| EP1869010A1 (en) * | 2005-04-11 | 2007-12-26 | Glaxo Group Limited | 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors |
| WO2006137527A1 (ja) | 2005-06-23 | 2006-12-28 | Kyowa Hakko Kogyo Co., Ltd. | チアゾール誘導体 |
| DK1921077T3 (en) | 2005-08-02 | 2017-10-23 | Kyowa Hakko Kirin Co Ltd | Means for treating and / or preventing sleep disorders |
| US7622492B2 (en) | 2005-08-31 | 2009-11-24 | Hoffmann-La Roche Inc. | Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase |
| JP2009517351A (ja) * | 2005-11-24 | 2009-04-30 | グラクソ グループ リミテッド | 化学物質 |
| DK2012839T3 (da) | 2006-04-07 | 2012-04-10 | Bactiguard Ab | Hidtil ukendte antimikrobielle substrater og anvendelser deraf |
| KR20090053923A (ko) * | 2006-09-22 | 2009-05-28 | 노파르티스 아게 | 헤테로시클릭 유기 화합물 |
| CN116003280B (zh) * | 2022-12-30 | 2024-11-19 | 合肥工业大学 | 一种芳基甲酰胺类化合物的光化学合成方法 |
| CN116712596A (zh) * | 2023-05-30 | 2023-09-08 | 北京福爱乐科技发展有限公司 | 一种用于体内创面喷涂型医用胶及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5202344A (en) * | 1990-12-11 | 1993-04-13 | G. D. Searle & Co. | N-substituted lactams useful as cholecystokinin antagonists |
| SI9520044B (sl) * | 1994-04-26 | 2004-08-31 | Aventis Pharmaceuticals Inc. | Inhibitorji Xa faktorja |
| US6034093A (en) * | 1995-06-07 | 2000-03-07 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
| US5731315A (en) * | 1995-06-07 | 1998-03-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds |
| AU4064597A (en) * | 1996-08-16 | 1998-03-06 | Du Pont Pharmaceuticals Company | Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
| GB9715894D0 (en) * | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic derivatives |
| US6403632B1 (en) * | 2000-03-01 | 2002-06-11 | Bristol Myers Squibb Pharma Co | Lactam metalloprotease inhibitors |
| US6025358A (en) * | 1998-06-11 | 2000-02-15 | G. D. Searle & Co. | Double prodrugs of potent GP IIb/IIIa antagonists |
| GB0114005D0 (en) * | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
| TW200307667A (en) * | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| US7169795B2 (en) * | 2003-09-30 | 2007-01-30 | Bristol Myers Squibb Company | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
-
2001
- 2001-12-21 GB GBGB0130705.7A patent/GB0130705D0/en not_active Ceased
-
2002
- 2002-12-19 TW TW091136597A patent/TWI262075B/zh not_active IP Right Cessation
- 2002-12-19 AR ARP020105014A patent/AR037928A1/es not_active Application Discontinuation
- 2002-12-19 MY MYPI20024789A patent/MY141579A/en unknown
- 2002-12-20 AU AU2002366747A patent/AU2002366747A1/en not_active Abandoned
- 2002-12-20 CA CA002471461A patent/CA2471461A1/en not_active Abandoned
- 2002-12-20 BR BR0215200-2A patent/BR0215200A/pt not_active IP Right Cessation
- 2002-12-20 RU RU2004122427/04A patent/RU2318807C2/ru not_active IP Right Cessation
- 2002-12-20 WO PCT/EP2002/014826 patent/WO2003053925A1/en not_active Ceased
- 2002-12-20 JP JP2003554642A patent/JP2005519885A/ja active Pending
- 2002-12-20 MX MXPA04006139A patent/MXPA04006139A/es active IP Right Grant
- 2002-12-20 US US10/499,529 patent/US20050059726A1/en not_active Abandoned
- 2002-12-20 NZ NZ533129A patent/NZ533129A/en unknown
- 2002-12-20 IL IL16245402A patent/IL162454A0/xx unknown
- 2002-12-20 HU HU0500137A patent/HUP0500137A2/hu unknown
- 2002-12-20 KR KR10-2004-7009675A patent/KR20040072666A/ko not_active Ceased
- 2002-12-20 PL PL02371008A patent/PL371008A1/xx not_active Application Discontinuation
- 2002-12-20 EP EP02805350A patent/EP1456172A1/en not_active Withdrawn
- 2002-12-20 CN CNB028282248A patent/CN100364971C/zh not_active Expired - Fee Related
-
2004
- 2004-05-27 ZA ZA200404147A patent/ZA200404147B/en unknown
- 2004-06-16 IS IS7316A patent/IS7316A/is unknown
- 2004-06-18 CO CO04057414A patent/CO5590896A2/es not_active Application Discontinuation
- 2004-07-13 NO NO20042990A patent/NO20042990L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005519885A5 (https=) | ||
| RU2436780C2 (ru) | Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы | |
| RU2203897C2 (ru) | Производные бензамидина, способ их получения, фармацевтическая композиция, способ ее получения и лекарственное средство | |
| RU2361860C2 (ru) | Новые замещенные 3-сера-индолы | |
| RU96115142A (ru) | Производные 5-(2-имидазолиниламино)бензимидазола, их получение и применение в качестве агонистов альфа-2-адреноцепторов | |
| JP2002501049A5 (https=) | ||
| RU2004122427A (ru) | Пирролидин-2-оны в качестве ингибиторов фактора ха | |
| RU2312106C2 (ru) | Замещенные 4-алкоксиоксазолпроизводные в качестве агонистов ppar | |
| JP2001526269A5 (https=) | ||
| JP2005537312A5 (https=) | ||
| RU2000131183A (ru) | Производные оксииминоалкановой кислоты | |
| JP2001526218A5 (https=) | ||
| RU2003134544A (ru) | Амиды антраниловой кислоты, способы их получения, их применение в качестве антиаритмических средств, а также содержащие их фармацевтические композиции | |
| JP2008513515A5 (https=) | ||
| RU2003114748A (ru) | Новые соединения, не являющиеся имидазолами | |
| RU2004122414A (ru) | Цис-2,4,5-трифенилимидазолины и их применение для лечения опухолевых заболеваний | |
| JP2006501201A5 (https=) | ||
| JP2021152063A5 (https=) | ||
| YU50302A (sh) | Nova heterociklična jedinjenja, njihove soli i njihova primena u medicini | |
| RU2007101236A (ru) | Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей | |
| JP2005526696A5 (https=) | ||
| RU99101081A (ru) | Режим введения ингибиторов н+, к+-атфазы | |
| JP2007507494A5 (https=) | ||
| RU2007106928A (ru) | Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы | |
| JP2009541387A5 (https=) |